Retraction Note: Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson’s disease: a meta-analysis [Mol Biol Rep, (2014), 41, (4463-4474), DOI 10.1007/s11033-014-3317-0];Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson's disease: A meta-analysis

Molecular Biology Reports

Volumn 41, Issue 7, 2014, Pages 4463-4474

  Gao, Zhan ^a   Fu, Hong Juan ^a   Xue, Ju Jun ^a   Wu, Zhi Xuan ^a   Zhao, Li Bo ^a  

^a Dept of Nasopharyngeal Carcinoma   (China)

Author keywords

ESR1; ESR2; Meta analysis; Parkinson's disease; VDR

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; ESTROGEN RECEPTOR ALPHA, HUMAN; VDR PROTEIN, HUMAN;

ALLELE MODEL; ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; DOMINANT MODEL; ESR1 GENE; ESR2 GENE; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; HETEROZYGOUS MODEL; HIGH RISK POPULATION; HOMOZYGOUS MODEL; HUMAN; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEWCASTLE OTTAWA SCALE; PARKINSON DISEASE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PUBLISHING; PYROSEQUENCING; RECESSIVE MODEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; VDR GENE; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MODEL; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HOMOZYGOTE; MALE; META ANALYSIS; PATHOPHYSIOLOGY; RISK; RISK FACTOR;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MODELS, GENETIC; ODDS RATIO; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RISK FACTORS;

EID: 84903386555     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-015-3892-8     Document Type: Erratum

References (37)

1. Liu NK, Xu XM (2011) Microrna in central nervous system trauma and degenerative disorders. Physiol Genomics 43:571-580. doi:10.1152/ physiolgenomics.00168.2010
2. Han M, Nagele E, DeMarshall C, Acharya N, Nagele R (2012) Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera. PLoS One 7:e32383. doi:10.1371/journal.pone.0032383
3. Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad M, Larsen JP (2008) Epidemiology of Parkinson's disease. J Neurol 255(Suppl 5):18-32. doi:10.1007/s00415-008-5004-3
4. Muangpaisan W, Mathews A, Hori H, Seidel D (2011) A systematic review of the worldwide prevalence and incidence of Parkinson's disease. J Med Assoc Thai 94:749-755
5. Marques S, Outeiro TF (2012) Epigenetics in Parkinson's and Alzheimer's diseases. Subcell Biochem 61:507-525. doi:10.1007/978-94-007-4525-4-22
6. Schapira AH, Jenner P (2011) Etiology and pathogenesis of Parkinson's disease. Mov Disord 26:1049-1055. doi:10.1002/mds.23732
7. Fang WL, Gao LB, Liang WB, Xue H, Bai P, Lv ML, Wang YY, Zhou B et al (2009) Association analysis of vitamin D receptor gene polymorphisms in Chinese population with asthma. Iran J Allergy Asthma Immunol 8:141-147.
8. Torok R, Torok N, Szalardy L, Plangar I, Szolnoki Z, Somogyvari F, Vecsei L, Klivenyi P (2013) Association of vitamin D receptor gene polymorphisms and Parkinson's disease in Hungarians. Neurosci Lett 551:70-74. doi:10.1016/j. neulet.2013.07.014
9. Yang L, Ma J, Zhang X, Fan Y, Wang L (2012) Protective role of the vitamin D receptor. Cell Immunol 279:160-166. doi:10.1016/j.cellimm.2012.10.002
10. McDonnell DP, Pike JW, O'Malley BW (1988) The vitamin D receptor: a primitive steroid receptor related to thyroid hormone receptor. J Steroid Biochem 30:41-46
11. Liu HX, Han X, Zheng XP, Li YS, Xie AM (2013) Association of vitamin d receptor gene polymorphisms with Parkinson disease. Chin J Med Genetics 30:13-16. doi:10.3760/cma.j.issn.1003-9406.2013.01.004
12. Lv Z, Tang B, Sun Q, Yan X, Guo J (2013) Association study between vitamin D receptor gene polymorphisms and patients with Parkinson disease in Chinese Han population. Int J Neurosci 123:60-64. doi:10.3109/00207454.2012. 726669
13. San Luciano M, Ozelius L, Lipton RB, Raymond D, Bressman SB, Saunders-Pullman R (2012) Gender differences in the IL6-174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's disease. Neurosci Lett 506:312-316. doi:10.1016/j.neulet.2011.11.032
14. Fiorito E, Katika MR, Hurtado A (2013) Cooperating transcription factors mediate the function of estrogen receptor. Chromosoma 122:1-12. doi:10.1007/s00412-012-0392-7
15. Al-Sweidi S, Morissette M, Bourque M, Di Paolo T (2011) Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease. Neuropharmacology 61:583-591. doi:10.1016/j.neuropharm.2011.04.031
16. Palacios N, Weisskopf M, Simon K, Gao X, Schwarzschild M, Ascherio A (2010) Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women. Parkinson Relat Disord 16:370-375. doi:10.1016/j.parkreldis.2010.02.012
17. Chung SJ, Armasu SM, Biernacka JM, Lesnick TG, Rider DN, Cunningham JM, Maraganore DM (2011) Variants in estrogenrelated genes and risk of Parkinson's disease. Mov Disord 26:1234-1242. doi:10.1002/Mds.23604
18. Westberg L, Hakansson A, Melke J, Shahabi HN, Nilsson S, Buervenich S, Carmine A, Ahlberg J et al (2004) Association between the estrogen receptor beta gene and age of onset of Parkinson's disease. Psychoneuroendocrinology 29:993-998. doi:10.1016/j.psyneuen.2003.08.010 (Pubitemid 38833525)
19. Lear TL, Adams MH, Sullivan ND, McDowell KJ, Bailey E (1998) Assignment of the horse progesterone receptor (PGR) and estrogen receptor (ESR1) genes to horse chromosomes 7 and 31, respectively, by in situ hybridization. Cytogenet Cell Genet 82:110-111 (Pubitemid 28472792)
20. Pavao M, Traish AM (2001) Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor alpha and beta. Steroids 66:1-16
21. Lin CH, Chen KH, Chen ML, Lin HI, Wu RM (2013) Vitamin D receptor genetic variants and Parkinson's disease in a Taiwanese population. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2013.10.094
22. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603-605. doi:10.1007/s10654-010-9491-z
23. Zintzaras E, Ioannidis JP (2005) Hegesma: genome search metaanalysis and heterogeneity testing. Bioinformatics 21:3672-3673. doi:10.1093/bioinformatics/ bti536 (Pubitemid 41264106)
24. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in metaanalysis. JAMA 295:676-680. doi:10.1001/jama.295.6.676 (Pubitemid 43209069)
25. Chen RJ, Zhang BS, Wang SM (2008) Association between estrogen receptor b gene polymorphisms and Parkinson disease. Natl Med J China 88:1185-1188. doi:10.3321/j.issn:0376-2491.2008.17.008
26. Han X, Xue L, Li Y, Chen B, Xie A (2012) Vitamin D receptor gene polymorphism and its association with Parkinson's disease in Chinese Han population. Neurosci Lett 525:29-33. doi:10.1016/j.neulet.2012.07.033
27. Isoe-Wada K, Maeda M, Yong J, Adachi Y, Harada H, Urakami K, Nakashima K (1999) Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia. Eur J Neurol 6:431-435 (Pubitemid 29371139)
28. Kim JS, Kim YI, Song C, Yoon I, Park JW, Choi YB, Kim HT, Lee KS (2005) Association of vitamin D receptor gene polymorphism and Parkinson's disease in Koreans. J Korean Med Sci 20:495-498 (Pubitemid 40905528)
29. Li XL, Cheng WD, Li J, Zheng YF, Guo CJ, Sun SG, Wang LX (2009) Does estrogen receptor gene polymorphism play a role in Parkinson's disease? Biomed Pharmacother 63:599-602. doi:10.1016/j.biopha.2008.09.007
30. Maraganore DM, Farrer MJ, McDonnell SK, Elbaz A, Schaid DJ, Hardy JA, Rocca WA (2002) Case-control study of estrogen receptor gene polymorphisms in Parkinson's disease. Mov Disord 17:509-512. doi:10.1002/mds.1253 (Pubitemid 36040963)
31. Mattila KM, Rinne JO, Roytta M, Laippala P, Lehtimaki T (2002) Lack of association between an estrogen receptor 1 gene polymorphism and Parkinson's disease with dementia. Acta Neurol Scand 106:128-130.
32. Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Saaksjarvi K, Heliovaara M (2010) Serum vitamin D and the risk of Parkinson disease. Arch Neurol 67:808-811. doi:10.1001/archneurol.2010.120
33. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13:100-105 (Pubitemid 36733998)
34. Butler MW, Burt A, Edwards TL, Zuchner S, Scott WK, Martin ER, Vance JM, Wang L (2011) Vitamin d receptor gene as a candidate gene for Parkinson disease. Ann Hum Genet 75:201-210. doi:10.1111/j.1469-1809.2010.00631.x
35. Velarde MC (2013) Pleiotropic actions of estrogen: a mitochondrial matter. Physiol Genomics 45:106-109. doi:10.1152/physiolgenomics.00155.2012
36. Martin-Millan M, Almeida M, Ambrogini E, Han L, Zhao H, Weinstein RS, Jilka RL, O'Brien CA et al (2010) The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol 24:323-334. doi:10.1210/me.2009-0354
37. Hakansson A, Westberg L, Nilsson S, Buervenich S, Carmine A, Holmberg B, Sydow O, Olson L et al (2005) Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 133B:88-92. doi:10.1002/ajmg.b. 30136 (Pubitemid 40175622)